HB 3410 amends provisions enacted in Senate Bill 951 to regulate how management services organizations (MSOs) may interact with professional medical entities in Oregon. The bill defines key terms such as management services, medical licensee, professional medical entity, and medical purpose, and then places limits on MSOs and their owners, officers, employees, contractors, and affiliates. In general, it prohibits MSOs from owning or controlling a majority of shares in a medical entity they serve, exercising proxy voting rights, restricting transfers of ownership, issuing stock, paying dividends, acquiring a majority interest, or exercising de facto control over administrative, business, or clinical operations in ways that affect clinical decision-making or the nature and quality of care.
The bill also voids contract terms that would authorize prohibited conduct and creates a private right of action for medical licensees or professional medical entities that suffer financial loss from violations. Available remedies include actual damages, injunctions, equitable relief, punitive damages, and attorney fees. At the same time, the bill preserves a number of exceptions, including certain passive or limited ownership arrangements, some physician relationships with MSOs, telemedicine entities without a physical patient-care location in Oregon, coordinated care organizations with preexisting arrangements, and several health care settings such as PACE organizations, behavioral health providers, hospitals, long-term care facilities, residential care facilities, tribal health programs, and certain crisis-line or substance use disorder providers.
HB 3410 also revises Oregon’s treatment of restrictive employment agreements for medical licensees. It generally voids noncompetition agreements that restrict the practice of medicine or nursing between a medical licensee and a person, MSO, hospital, or hospital-affiliated clinic, but preserves enforceability in limited circumstances tied to ownership interests, recruitment investment, and specified time limits. The bill further voids nondisclosure and nondisparagement agreements between medical licensees and MSOs or hospitals in most cases, while allowing them in settlement agreements or after termination/voluntary departure, except where the licensee is making a good-faith report of suspected legal violations to authorities or the employer.
In terms of state law impact, HB 3410 narrows the ability of corporate or management entities to influence medical practice and strengthens protections for clinicians’ professional independence, mobility, and whistleblowing. It amends multiple sections of the 2025 health care legislation and sets different effective dates, including immediate effect under an emergency clause and delayed application for some preexisting entities and transactions until January 1, 2029. The bill therefore affects MSOs, hospitals, professional corporations, physician groups, nurse practitioners, physician associates, naturopathic physicians, and other health care organizations operating in Oregon.
The overall sentiment appears broadly supportive, with strong majorities in both chambers and committee approval on amended versions. The votes suggest the bill was acceptable to most legislators, though not unanimous. The main points of contention likely centered on how far the state should go in limiting MSO control, whether the bill could disrupt existing business arrangements, and how broadly to ban noncompete, nondisclosure, and nondisparagement provisions in health care employment and contracting. The detailed exemptions and delayed applicability for older entities indicate an effort to balance clinician protections with concerns from health systems, MSOs, and other affected providers.
HB 3410 amends Oregon’s 2025 health care law to restrict management services organizations from controlling professional medical entities in ways that affect clinical judgment, ownership, governance, or business operations tied to patient care. It also voids certain contract provisions, creates a civil cause of action with damages and fee-shifting, and limits enforceability of noncompetition, nondisclosure, and nondisparagement agreements for medical licensees. The bill affects statutes governing professional medical entities, MSOs, and employment restrictions in health care, with phased applicability for existing organizations and immediate application for some new arrangements.
The main controversy likely involved the scope of restrictions on MSOs and whether the bill would interfere with existing health care business models, especially for hospitals, coordinated care organizations, telemedicine entities, and behavioral health providers. Another likely point of contention was the bill’s broad invalidation of noncompetition, nondisclosure, and nondisparagement agreements, which some stakeholders may have viewed as necessary for recruitment, retention, and business protection. The bill’s many carveouts and delayed effective dates for preexisting entities suggest compromise between advocates for clinician autonomy and opponents concerned about operational and contractual disruption.